Subscribe Now


Trending News

Work With Us

Who is T1D Exchange?

Data Driven Research to Improve T1D Outcomes for All

T1D Exchange is a nonprofit organization that facilitates research and quality improvement, driving improved outcomes for people living with type 1 diabetes (T1D) and type 2 diabetes (T2D). Through quality improvement and collaboration, we harness data and insights to advance diabetes research, identify gaps in data and unmet needs in diabetes care, refine best practices, and ultimately improve the quality of life for all people living with diabetes.

T1D Exchange was established in 2010 with ongoing support from The Leona M. and Harry B. Helmsley Charitable Trust.

What We Do

In collaboration with our partners, we collect and analyze data that will benefit people living with diabetes both now and in the future.

We aggregate both clinical outcomes and real-world data to obtain a comprehensive and accurate picture of diabetes disease progression, its clinical management, and the impact on patients living with diabetes. Using this data, we generate and share relevant insights that can make meaningful population health improvements, including better products, policy changes, and insurance coverage that increases healthcare utilization and reduces inequities in care.

Through our expansive network, T1D Exchange reaches over 100,000 people impacted by diabetes. Our programs allow us to facilitate research, gather and analyze RWD, drive quality improvement, and improve health equity for people living with diabetes.

Custom Research Capabilities
Quality Improvement Collaborative
The Online Registry
Fill Your Study Faster
Health Equity in Diabetes
Our Online Community

For Custom Research and Sponsorship Opportunities:

Dave Walton, MBA

Chief Executive Officer

Debbie Taylor

Senior Director, Marketing & Business Development

Kellee Miller, PhD, MPH

Senior Director, Research Services & Business Development

For the T1D Exchange Quality Improvement Collaborative (T1DX-QI) and Health Equity:

Osagie Ebekozien, MD, MPH, CPHQ

Executive Vice President, Chief Medical Officer

For the T1D Exchange Registry and Outcomes Research:

Wendy Wolf, PhD

Vice President, Registry & Research